Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Reply to J. Wang et al.

Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Newman AM, Dührsen U, Hüttmann A, Meignan M, Casasnovas O, Westin JR, Roschewski M, Wilson WH, Gaidano G, Rossi D, Diehn M, Alizadeh AA.

J Clin Oncol. 2019 Mar 20;37(9):755-757. doi: 10.1200/JCO.18.01907. Epub 2019 Feb 12. No abstract available.

PMID:
30753108
2.

Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma.

Kurtz DM, Scherer F, Jin MC, Soo J, Craig AFM, Esfahani MS, Chabon JJ, Stehr H, Liu CL, Tibshirani R, Maeda LS, Gupta NK, Khodadoust MS, Advani RH, Levy R, Newman AM, Dührsen U, Hüttmann A, Meignan M, Casasnovas RO, Westin JR, Roschewski M, Wilson WH, Gaidano G, Rossi D, Diehn M, Alizadeh AA.

J Clin Oncol. 2018 Oct 1;36(28):2845-2853. doi: 10.1200/JCO.2018.78.5246. Epub 2018 Aug 20.

3.

Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.

Scherer F, Kurtz DM, Newman AM, Stehr H, Craig AF, Esfahani MS, Lovejoy AF, Chabon JJ, Klass DM, Liu CL, Zhou L, Glover C, Visser BC, Poultsides GA, Advani RH, Maeda LS, Gupta NK, Levy R, Ohgami RS, Kunder CA, Diehn M, Alizadeh AA.

Sci Transl Med. 2016 Nov 9;8(364):364ra155.

4.

Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.

Dunleavy K, Pittaluga S, Maeda LS, Advani R, Chen CC, Hessler J, Steinberg SM, Grant C, Wright G, Varma G, Staudt LM, Jaffe ES, Wilson WH.

N Engl J Med. 2013 Apr 11;368(15):1408-16. doi: 10.1056/NEJMoa1214561.

5.

Clinical outcome prediction by microRNAs in human cancer: a systematic review.

Nair VS, Maeda LS, Ioannidis JP.

J Natl Cancer Inst. 2012 Apr 4;104(7):528-40. doi: 10.1093/jnci/djs027. Epub 2012 Mar 6. Review.

6.

A retrospective study evaluating the efficacy and safety of bendamustine in the treatment of mantle cell lymphoma.

Warsch S, Hosein PJ, Maeda LS, Alizadeh AA, Lossos IS.

Leuk Lymphoma. 2012 Jul;53(7):1299-1305. doi: 10.3109/10428194.2011.649476. Epub 2012 Jan 31.

7.

Current concepts and controversies in the management of early stage Hodgkin lymphoma.

Maeda LS, Lee M, Advani RH.

Leuk Lymphoma. 2011 Jun;52(6):962-71. doi: 10.3109/10428194.2011.557455. Epub 2011 Apr 4. Review.

8.

Stage I-IIA non-bulky Hodgkin's lymphoma. Is further distinction based on prognostic factors useful? The Stanford experience.

Advani RH, Hoppe RT, Maeda LS, Baer DM, Mason J, Rosenberg SA, Horning SJ.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1374-9. doi: 10.1016/j.ijrobp.2010.07.041. Epub 2010 Oct 8.

9.

The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma.

Maeda LS, Advani RH.

Curr Opin Oncol. 2009 Sep;21(5):397-400. doi: 10.1097/CCO.0b013e32832f3ca3. Review.

PMID:
19606035
10.

Transcription arrest at an abasic site in the transcribed strand of template DNA.

Tornaletti S, Maeda LS, Hanawalt PC.

Chem Res Toxicol. 2006 Sep;19(9):1215-20.

PMID:
16978026
11.

Transcriptional inhibition by an oxidized abasic site in DNA.

Wang Y, Sheppard TL, Tornaletti S, Maeda LS, Hanawalt PC.

Chem Res Toxicol. 2006 Feb;19(2):234-41.

PMID:
16485899
12.

Effect of 8-oxoguanine on transcription elongation by T7 RNA polymerase and mammalian RNA polymerase II.

Tornaletti S, Maeda LS, Kolodner RD, Hanawalt PC.

DNA Repair (Amst). 2004 May 4;3(5):483-94.

PMID:
15084310
13.

Effect of thymine glycol on transcription elongation by T7 RNA polymerase and mammalian RNA polymerase II.

Tornaletti S, Maeda LS, Lloyd DR, Reines D, Hanawalt PC.

J Biol Chem. 2001 Nov 30;276(48):45367-71. Epub 2001 Sep 24.

Supplemental Content

Loading ...
Support Center